14/04/2024
Late breaking research assessing real-world CV safety of romosozumab vs alternative osteoanabolic therapies used for treatment of severe osteoporosis showing fewer adverse CV events when compared to PTH analogue therapy.
Ιατρικό κέντρο Ενδοκρινολογίας & Διαβητολογίας
Τσιμισκή 70
Thessaloníki
54622
| Monday | 09:00 - 14:00 |
| 17:00 - 21:00 | |
| Tuesday | 09:00 - 14:00 |
| 17:00 - 21:00 | |
| Wednesday | 09:00 - 17:00 |
| Thursday | 09:00 - 14:00 |
| 17:00 - 21:00 | |
| Friday | 09:00 - 17:00 |
Be the first to know and let us send you an email when Ενδοκρινολογικό Διαβητολογικό Ιατρείο Δήμητρα Μπογδάνου - Florian Schlereth posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.